Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

This study has been terminated.
(Slow rates of accrual in North America, enrollment of more than 100 patients in a global study to confirm safe dose.)
Sponsor:
Information provided by:
Viventia Biotech
ClinicalTrials.gov Identifier:
NCT00272181
First received: January 3, 2006
Last updated: September 8, 2008
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2007
  Estimated Primary Completion Date: No date given